| |
|
|
|
|
|
|
|
|
|
|
THBI is continuing to communicate and work with policy leaders, industry partners and Texas entities to ensure the state of Texas is on the forefront of combating coronavirus, and taking proper action to keep the state safe during the global outbreak. We have focused on creating timely virtual meetings for our members and policy makers to highlight the latest developments and challenges in the fight against COVID-19. If you would like to be a part of these conversations, contact julia@thbi.com to learn more about becoming a member. |
|
|
|
Virtual Texas Healthcare and Bioscience Policy Summit, June 18thAs the leading health policy voice in the state, THBI has been influencing legislation that has led to economic investment and medical breakthroughs for over 20 years. This annual Summit is the premier health policy conference in Texas. The event will include panel discussions and keynote presentations focused on public health policy and our industry's response to COVID-19. This is a critical time for our industry and we look forward to leading important conversations for policy makers to hear. Registration is complimentary.
Thank you sponsors PhRMA, Merck, Pfizer, UT Health San Antonio,Otsuka, Cancer Insight and Dispersol Technologies.
Sponsorship opportunities are still available. Email jhl@thbi.com to learn more.
|
As the world has been dealing with the implications of the COVID-19 pandemic, BIO has been working with partners and member companies on business continuity, mitigation and contingency planning. As part of BIO Business Solutions Cost Savings Program, we have several benefits to help you run your business, access resources and reduce spending. |
To become a THBI member and gain access to the BIO Business Solutions purchasing program, email julia@thbi.com. |
THBI is the Texas policy voice for the healthcare and bioscience industry. With a focus on advocacy, public policy and industry vitalization, THBI works with government and industry leaders to enhance and further establish the life sciences in Texas, and to promote effective legislation at the state and federal level.
There is no better time to join the conversation and become a member of THBI. Our members are on the forefront of collaboration and the research and development of vaccines, therapeutics and diagnostics to combat COVID-19. No matter the size of your company or level of involvement, your participation at the table is important. To learn more about membership opportunities, email julia@thbi.com. |
|
New report shows nearly 260
vaccines in development, including dozens for COVID-19
Today, biopharmaceutical companies are working with stakeholders across the research and development (R&D) ecosystem to develop new ways of preventing and treating illnesses with innovative vaccines.
|
Current challenges and successes in the battle against virusesVaccines are a first line of defense in preventing viral illnesses, but once diagnosed what are possible next steps? Join Johnson & Johnson for a talk with several leading scientists as we discuss the challenges and success in the virus battle today and as we prepare for the future. |
National Minority Health Month in the age of COVID-19As we observe National Minority Health this month, the COVID-19 pandemic and the devastating impact of it on communities of color cannot be ignored. |
Austin Community College awarded a National Biotechnology Center, named InnovATEBIO, through a $7.5 million grant
from the National Science Foundation (NSF). The funding is to develop a new national
biotechnology education center to address the rapidly growing need for highly
skilled technicians in biotechnology. The InnovATEBIO center will consolidate several biotech education projects
into a national network to share best practices and expand research
opportunities for students at two-year institutions.
|
TexasWorkforce Commission (TWC)At TWC, the health and well-being of our employers,employees and communities is our top priority. We understand the concern anduncertainty you may be experiencing surrounding the coronavirus (COVID-19) andare committed to being responsive to the needs of our customers.
|
Biotechnology Innovation Organization (BIO) Coronavirus Business Resource Center
As many BIO members work to develop diagnostics, vaccines and treatments to address the global COVID-19 outbreak, BIO has provided resources to help companies continue their operations with minimum disruption and keep their employees safe and healthy. |
THBI has published a COVID-19 page on www.thbi.com for more helpful resources and an archive of the THBI COVID-19 email updates. |
|
|
|
|
|
Copyright © 2020 THBI. All rights reserved.
Our mailing address is:
807 Brazos Street, Suite 607Austin, TX 78701
This message is sent to you because your email address is on our subscribers list. If you are not interested in receiving more emails like this one, click here to unsubscribe.
|
|
|
|
|
|
|
|
|
